Palatin Technologies Inc./$PTN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
- Ticker
- $PTN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 25
- Headquarters
- Princeton, United States
- Website
- palatin.com
PTN Metrics
BasicAdvanced
$13M
-
-$2.96
-0.04
-
Price and volume
Market cap
$13M
Beta
-0.04
52-week high
$31.00
52-week low
$4.51
Average daily volume
37K
Financial strength
Current ratio
4.608
Quick ratio
4.398
Long term debt to equity
0.01
Total debt to equity
0.033
Interest coverage (TTM)
-1,288.77%
Profitability
EBITDA (TTM)
-8.606
Gross margin (TTM)
6.19%
Net profit margin (TTM)
-63.54%
Operating margin (TTM)
-65.74%
Revenue per employee (TTM)
$530,000
Management effectiveness
Return on assets (TTM)
-91.90%
Return on equity (TTM)
-877.53%
Valuation
Price to revenue (TTM)
1.477
Price to book
1.9
Price to tangible book (TTM)
1.9
Price to free cash flow (TTM)
-1.434
Free cash flow yield (TTM)
-69.74%
Free cash flow per share (TTM)
-4.805
Growth
Earnings per share change (TTM)
-90.78%
3-year revenue growth (CAGR)
39.53%
3-year earnings per share growth (CAGR)
-70.06%
10-year earnings per share growth (CAGR)
-43.80%
What the Analysts think about PTN
Analyst ratings (Buy, Hold, Sell) for Palatin Technologies Inc. stock.
Analyst projections of the future price of Palatin Technologies Inc. stock.
PTN Financial Performance
Revenues and expenses
PTN Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.